52 related articles for article (PubMed ID: 26629888)
21. CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.
Lupia M; Angiolini F; Bertalot G; Freddi S; Sachsenmeier KF; Chisci E; Kutryb-Zajac B; Confalonieri S; Smolenski RT; Giovannoni R; Colombo N; Bianchi F; Cavallaro U
Stem Cell Reports; 2018 Apr; 10(4):1412-1425. PubMed ID: 29551673
[TBL] [Abstract][Full Text] [Related]
22. Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction.
Wang W; Cai Q; Zhou F; Liu J; Jin X; Ni P; Lu M; Wang G; Zhang J
Redox Biol; 2018 May; 15():253-265. PubMed ID: 29291545
[TBL] [Abstract][Full Text] [Related]
23. The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.
Matondo A; Jo YH; Shahid M; Choi TG; Nguyen MN; Nguyen NNY; Akter S; Kang I; Ha J; Maeng CH; Kim SY; Lee JS; Kim J; Kim SS
Sci Rep; 2017 Aug; 7(1):9689. PubMed ID: 28851888
[TBL] [Abstract][Full Text] [Related]
24. Up-regulated Ectonucleotidases in Fas-Associated Death Domain Protein- and Receptor-Interacting Protein Kinase 1-Deficient Jurkat Leukemia Cells Counteract Extracellular ATP/AMP Accumulation via Pannexin-1 Channels during Chemotherapeutic Drug-Induced Apoptosis.
Boyd-Tressler AM; Lane GS; Dubyak GR
Mol Pharmacol; 2017 Jul; 92(1):30-47. PubMed ID: 28461585
[TBL] [Abstract][Full Text] [Related]
25. CD73s protection of epithelial integrity: Thinking beyond the barrier.
Bowser JL; Broaddus RR
Tissue Barriers; 2016; 4(4):e1224963. PubMed ID: 28123924
[TBL] [Abstract][Full Text] [Related]
26. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
Bonnin N; Armandy E; Carras J; Ferrandon S; Battiston-Montagne P; Aubry M; Guihard S; Meyronet D; Foy JP; Saintigny P; Ledrappier S; Jung A; Rimokh R; Rodriguez-Lafrasse C; Poncet D
Oncotarget; 2016 Jul; 7(28):44023-44038. PubMed ID: 27281619
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors.
Chowanadisai W; Messerli SM; Miller DH; Medina JE; Hamilton JW; Messerli MA; Brodsky AS
PLoS One; 2016; 11(3):e0151089. PubMed ID: 26986722
[TBL] [Abstract][Full Text] [Related]
28. Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E.
Kordaß T; Osen W; Eichmüller SB
Front Immunol; 2018; 9():813. PubMed ID: 29720980
[TBL] [Abstract][Full Text] [Related]
29. Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target.
Yang J; Liao X; Yu J; Zhou P
Curr Med Chem; 2018; 25(19):2260-2271. PubMed ID: 29345574
[TBL] [Abstract][Full Text] [Related]
30. Activity of ecto-5'-nucleotidase (NT5E/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes.
Bertoni APS; Bracco PA; de Campos RP; Lutz BS; Assis-Brasil BM; Meyer ELS; Saffi J; Braganhol E; Furlanetto TW; Wink MR
Mol Cell Endocrinol; 2019 Jan; 479():54-60. PubMed ID: 30184475
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).
Snider NT; Altshuler PJ; Wan S; Welling TH; Cavalcoli J; Omary MB
Mol Biol Cell; 2014 Dec; 25(25):4024-33. PubMed ID: 25298403
[TBL] [Abstract][Full Text] [Related]
32. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
Hu S; Meng F; Yin X; Cao C; Zhang G
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
[TBL] [Abstract][Full Text] [Related]
33. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity.
Wang H; Lee S; Nigro CL; Lattanzio L; Merlano M; Monteverde M; Matin R; Purdie K; Mladkova N; Bergamaschi D; Harwood C; Syed N; Szlosarek P; Briasoulis E; McHugh A; Thompson A; Evans A; Leigh I; Fleming C; Inman GJ; Hatzimichael E; Proby C; Crook T
Br J Cancer; 2012 Apr; 106(8):1446-52. PubMed ID: 22454080
[TBL] [Abstract][Full Text] [Related]
34. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
[TBL] [Abstract][Full Text] [Related]
35. A Systems Oncology Approach Identifies NT5E as a Key Metabolic Regulator in Tumor Cells and Modulator of Platinum Sensitivity.
Nevedomskaya E; Perryman R; Solanki S; Syed N; Mayboroda OA; Keun HC
J Proteome Res; 2016 Jan; 15(1):280-90. PubMed ID: 26629888
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]